CORONARY HEART DISEASE & STROKE IN PEOPLE AGED 65-84

冠状动脉心脏疾病

基本信息

  • 批准号:
    2595077
  • 负责人:
  • 金额:
    $ 94.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1988
  • 资助国家:
    美国
  • 起止时间:
    1988-06-01 至 2000-05-31
  • 项目状态:
    已结题

项目摘要

The Cardiovascular Health Study is a population-based, longitudinal study of risk factors for the development and progression of coronary heart disease and stroke in adults over the age of 65 years. Both risk factors established in middle-aged population and suspected risk factors are examined and include hypercholesterolemia, hypertension, glucose intolerance and diabetes, and cigarette smoking. Since atherosclerosis is prevalent in the elderly, the study focuses on factors thought to induce clinically overt disease. It does so in two ways: (1) It assesses the prediction of clinical disease from non-invasive measure of preclinical disease, such as carotid atherosclerosis, left ventricular impairment, and arrhythmias of episodes of myocardial ischemia. (2) Since cardiovascular events may occur in elderly people as a result of health or life circumstances which may have changed in the months preceding the event, the study contacts participants at frequent intervals to evaluate their status with respect to concurrent disease, social support networks, stressful life situations, diet, physical activity, and other risk factors. The study has three secondary objectives pertaining to the elderly populations: (1) to evaluate the factors associated with preclinical cardiovascular disease such as carotid atherosclerosis, left ventricular impairment and episodes of arrhythmia or myocardial ischemia; (2) to evaluate predictors of disability, institutionalization and mortality in participants who have coronary heart disease or stroke; and (3) to measure the utilization and impact of medical care services for coronary heart disease and stroke. Currently, risk associations are identified with clinical disease by the accumulation of events. Risk estimates are compared in subgroups of participants, such as women versus men, African-American versus Caucasian, those older versus younger than 75 years, or those with versus without prevalent clinical or subclinical disease. Risk estimates are compared in subtypes of disease, such as fatal versus non-fatal myocardial infarction, symptomatic versus silent myocardial ischemia, or fatal versus non-fatal stroke. Estimates are compared of longer-term (5-10 year) versus short-term (1-3 year) CVD risk. The study is also; determining whether presence or progression of subclinical disease (abnormalities detected non-invasively without signs or symptoms) are better predictors of clinical disease than traditional risk factors; identifying determinants of change in subclinical disease; identifying characteristics of subgroups at low risk for developing CVD (in whom preventive measures may be unnecessary). The contractor serves as a Field Center for the study. The duties of the Field Centers include recruitment of an appropriate cohort, cohort interviews and clinical examinations, surveillance of the cohort, and data analysis.
心血管健康研究是一项基于人群的纵向研究

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN A ROBBINS其他文献

JOHN A ROBBINS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN A ROBBINS', 18)}}的其他基金

CARDIOVASCULAR CONSEQUENCES OF SLEEP APNEA
睡眠呼吸暂停对心血管的影响
  • 批准号:
    2771407
  • 财政年份:
    1994
  • 资助金额:
    $ 94.67万
  • 项目类别:
Sleep Heart Health Study
睡眠心脏健康研究
  • 批准号:
    6822180
  • 财政年份:
    1994
  • 资助金额:
    $ 94.67万
  • 项目类别:
SLEEP HEART HEALTH STUDY
睡眠心脏健康研究
  • 批准号:
    6526754
  • 财政年份:
    1994
  • 资助金额:
    $ 94.67万
  • 项目类别:
Sleep Heart Health Study
睡眠心脏健康研究
  • 批准号:
    6950763
  • 财政年份:
    1994
  • 资助金额:
    $ 94.67万
  • 项目类别:
CARDIOVASCULAR CONSEQUENCES OF SLEEP APNEA
睡眠呼吸暂停对心血管的影响
  • 批准号:
    2232049
  • 财政年份:
    1994
  • 资助金额:
    $ 94.67万
  • 项目类别:
SLEEP HEART HEALTH STUDY
睡眠心脏健康研究
  • 批准号:
    6184099
  • 财政年份:
    1994
  • 资助金额:
    $ 94.67万
  • 项目类别:
SLEEP HEART HEALTH STUDY
睡眠心脏健康研究
  • 批准号:
    6662550
  • 财政年份:
    1994
  • 资助金额:
    $ 94.67万
  • 项目类别:
CARDIOVASCULAR CONSEQUENCES OF SLEEP APNEA
睡眠呼吸暂停对心血管的影响
  • 批准号:
    2232050
  • 财政年份:
    1994
  • 资助金额:
    $ 94.67万
  • 项目类别:
SLEEP HEART HEALTH STUDY
睡眠心脏健康研究
  • 批准号:
    2909034
  • 财政年份:
    1994
  • 资助金额:
    $ 94.67万
  • 项目类别:
CARDIOVASCULAR CONSEQUENCES OF SLEEP APNEA
睡眠呼吸暂停对心血管的影响
  • 批准号:
    2519474
  • 财政年份:
    1994
  • 资助金额:
    $ 94.67万
  • 项目类别:

相似海外基金

Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
  • 批准号:
    24K21101
  • 财政年份:
    2024
  • 资助金额:
    $ 94.67万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
  • 批准号:
    10537602
  • 财政年份:
    2023
  • 资助金额:
    $ 94.67万
  • 项目类别:
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
  • 批准号:
    2880683
  • 财政年份:
    2023
  • 资助金额:
    $ 94.67万
  • 项目类别:
    Studentship
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
  • 批准号:
    23K15842
  • 财政年份:
    2023
  • 资助金额:
    $ 94.67万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
2023 Atherosclerosis
2023 动脉粥样硬化
  • 批准号:
    10675221
  • 财政年份:
    2023
  • 资助金额:
    $ 94.67万
  • 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
  • 批准号:
    10652788
  • 财政年份:
    2023
  • 资助金额:
    $ 94.67万
  • 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
  • 批准号:
    10570469
  • 财政年份:
    2023
  • 资助金额:
    $ 94.67万
  • 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
  • 批准号:
    10585070
  • 财政年份:
    2023
  • 资助金额:
    $ 94.67万
  • 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
  • 批准号:
    10619831
  • 财政年份:
    2023
  • 资助金额:
    $ 94.67万
  • 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS - TOPMED
动脉粥样硬化的多种族研究 - TOPMED
  • 批准号:
    10974007
  • 财政年份:
    2023
  • 资助金额:
    $ 94.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了